We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HJGA
301
Hardman Johnston Global Advisors
Connecticut
$2.64M +$2.63M +67,439 New
NLI
302
Nippon Life Insurance
Japan
$2.64M +$2.62M +67,344 New
N
303
Natixis
France
$2.64M +$2.62M +67,253 New
AWCI
304
Alpine Woods Capital Investors
New York
$2.63M +$2.62M +67,225 New
GT
305
Glenmede Trust
Pennsylvania
$2.62M +$2.61M +66,903 New
AA
306
Apriem Advisors
California
$2.62M +$2.6M +66,780 New
RJFSA
307
Raymond James Financial Services Advisors
Florida
$2.62M +$2.6M +66,759 New
CRC
308
Curi RMB Capital
Illinois
$2.6M +$2.58M +66,326 New
CA
309
Continental Advisors
Utah
$2.6M +$2.58M +66,300 New
LBC
310
Lowe Brockenbrough & Co
Virginia
$2.58M +$2.56M +65,710 New
LAM
311
Lingohr Asset Management
Germany
$2.57M +$2.55M +65,600 New
AAM
312
Advisors Asset Management
Colorado
$2.55M +$2.53M +65,061 New
CCM
313
Covington Capital Management
California
$2.53M +$2.51M +64,549 New
KFS
314
Kurt F. Somerville
$2.52M +$2.5M +64,275 New
TMAM
315
Tokio Marine Asset Management
Japan
$2.51M +$2.49M +63,941 New
EI
316
EDMP Inc
Florida
$2.5M +$2.49M +63,904 New
CIA
317
Choate Investment Advisors
Massachusetts
$2.49M +$2.48M +63,607 New
CD
318
Carl Domino
Florida
$2.48M +$2.46M +63,281 New
CANY
319
Caxton Associates (New York)
New York
$2.44M +$2.43M +62,300 New
WAM
320
Wallington Asset Management
Indiana
$2.43M +$2.41M +62,000 New
RJA
321
Robshaw & Julian Associates
New York
$2.41M +$2.4M +61,528 New
PSC
322
Prentiss Smith & Co
Vermont
$2.41M +$2.39M +61,496 New
BCIM
323
British Columbia Investment Management
British Columbia, Canada
$2.4M +$2.39M +61,345 New
DIA
324
Denver Investment Advisors
Colorado
$2.4M +$2.38M +61,109 New
CB
325
Commerce Bank
Missouri
$2.39M +$2.37M +60,908 New
11 12
13
14 15

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.